| Preparation and optimization of poly (lactic acid) nanoparticles loaded with fisetin to improve anti-cancer therapy C Feng, X Yuan, K Chu, H Zhang, W Ji, M Rui International journal of biological macromolecules 125, 700-710, 2019 | 86 | 2019 |
| Targeted biomimetic nanoparticles for synergistic combination chemotherapy of paclitaxel and doxorubicin M Rui, Y Xin, R Li, Y Ge, C Feng, X Xu Molecular pharmaceutics 14 (1), 107-123, 2017 | 79 | 2017 |
| A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells J Mai, S Song, M Rui, D Liu, Q Ding, J Peng, Y Xu Journal of Controlled Release 139 (3), 174-181, 2009 | 59 | 2009 |
| Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells M Rui, Y Qu, T Gao, Y Ge, C Feng, X Xu International journal of nanomedicine, 217-237, 2017 | 52 | 2017 |
| In vitro and in vivo study of a nanoliposomal cisplatin as a radiosensitizer X Zhang, H Yang, K Gu, J Chen, M Rui, GL Jiang International journal of nanomedicine, 437-444, 2011 | 50 | 2011 |
| Effects of surface displayed targeting ligand GE11 on liposome distribution and extravasation in tumor H Tang, X Chen, M Rui, W Sun, J Chen, J Peng, Y Xu Molecular pharmaceutics 11 (10), 3242-3250, 2014 | 49 | 2014 |
| Three chiral ionic liquids as additives for enantioseparation in capillary electrophoresis and their comparison with conventional modifiers Q Zhang, X Qi, C Feng, S Tong, M Rui Journal of Chromatography A 1462, 146-152, 2016 | 47 | 2016 |
| Investigation of the synergistic effect of chiral ionic liquids as additives in non-aqueous capillary electrophoresis for enantioseparation S Ren, S Xue, X Sun, M Rui, L Wang, Q Zhang Journal of Chromatography A 1609, 460519, 2020 | 41 | 2020 |
| Recombinant high density lipoprotein nanoparticles for target-specific delivery of siRNA M Rui, H Tang, Y Li, X Wei, Y Xu Pharmaceutical research 30, 1203-1214, 2013 | 39 | 2013 |
| Ratiometric co-encapsulation and co-delivery of doxorubicin and paclitaxel by tumor-targeted lipodisks for combination therapy of breast cancer C Feng, H Zhang, J Chen, S Wang, Y Xin, Y Qu, Q Zhang, W Ji, ... International Journal of Pharmaceutics 560, 191-204, 2019 | 38 | 2019 |
| Enhanced enantioselectivity of native α‐cyclodextrins by the synergy of chiral ionic liquids in capillary electrophoresis Q Zhang, J Zhang, S Xue, M Rui, B Gao, A Li, J Bai, Z Yin, EM Anochie Journal of separation science 41 (24), 4525-4532, 2018 | 34 | 2018 |
| Tumor-specific delivery of doxorubicin through conjugation of pH-responsive peptide for overcoming drug resistance in cancer C Feng, M Rui, H Shen, Y Xin, J Zhang, J Li, L Yue, W Lai, X Xu International journal of pharmaceutics 528 (1-2), 322-333, 2017 | 34 | 2017 |
| Gene expression data based deep learning model for accurate prediction of drug-induced liver injury in advance C Feng, H Chen, X Yuan, M Sun, K Chu, H Liu, M Rui Journal of chemical information and modeling 59 (7), 3240-3250, 2019 | 28 | 2019 |
| Recombinant high-density lipoprotein nanoparticles containing gadolinium-labeled cholesterol for morphologic and functional magnetic resonance imaging of the liver M Rui, W Guo, Q Ding, X Wei, J Xu, Y Xu International Journal of Nanomedicine, 3751-3768, 2012 | 27 | 2012 |
| Use of gamithromycin as a chiral selector in capillary electrophoresis S Ren, Q Zhang, S Xue, S Liu, M Rui Journal of Chromatography A 1624, 461099, 2020 | 22 | 2020 |
| Targeting and liposomal drug delivery to CD40L expressing T cells for treatment of autoimmune diseases Q Ding, X Si, D Liu, J Peng, H Tang, W Sun, M Rui, Q Chen, L Wu, Y Xu Journal of controlled release 207, 86-92, 2015 | 20 | 2015 |
| Synthesis of quinolinium-based probes and studies of their effects for selective G-quadruplex DNA targeting MQ Wang, XN Liu, ZJ Guo, C Feng, M Rui New Journal of Chemistry 42 (7), 4933-4939, 2018 | 12 | 2018 |
| Reimaging biological barriers affecting distribution and extravasation of PEG/peptide-modified liposomes in xenograft SMMC7721 tumor H Tang, M Rui, J Mai, W Guo, Y Xu Acta Pharmaceutica Sinica B 10 (3), 546-556, 2020 | 11 | 2020 |
| Deep learning-based multi-drug synergy prediction model for individually tailored anti-cancer therapies S She, H Chen, W Ji, M Sun, J Cheng, M Rui, C Feng Frontiers in Pharmacology 13, 1032875, 2022 | 7 | 2022 |
| Identification of potential RBPJ-specific inhibitors for blocking notch signaling in breast cancer using a drug repurposing strategy M Rui, M Cai, Y Zhou, W Zhang, L Gao, K Mi, W Ji, D Wang, C Feng Pharmaceuticals 15 (5), 556, 2022 | 7 | 2022 |
